Effects of cytochrome P450 arachidonic acid epoxygenases on the proliferation of tumor cells

Chinese Journal of Cancer

Volumn 28, Issue 1, 2009, Pages 14-19

  Jiang, Jian Gang ^a   Shen, Gui Fen ^a   Chen, Chen ^a   Fu, Xian Ning ^a   Wang, Dao Wen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Arachidonic acid; Cytochrome P450; Epoxygenase; Proliferation; Signal transduction pathway; Tumor cells

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2J2; CYTOCHROME P450 ARACHIDONIC ACID EPOXYGENASE; CYTOCHROME P450 F87V; EPIDERMAL GROWTH FACTOR RECEPTOR; GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PARVOVIRUS VECTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN TUMOR; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOCHROME P-450 ENZYME SYSTEM; DIYNES; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ACIDS, UNSATURATED; HUMANS; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 67749091074     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Teichert J, Baumann F, Chao Q, et al. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride[J]. Cancer Chemother Pharmacol, 2007,59(6):759-770.
2. Nwankwo JO. Significant transcriptional down-regulation of the human MDR1 gene by beta-naphthoflavone: a proposed hypothesis linking potent CYP gene induction to MDR1 inhibition [J]. Med Hypotheses, 2007,68(3):661-669.
3. Enayetallah AE, French RA, Grant DF. Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms[J]. J Mol Histol, 2006,37(3-4):133-141.
4. Jiang JG, Chen CL, Card JW, et al. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors[J]. Cancer Res, 2005,65(11):4707-4715.
5. Bajo AM, Schally AV, Krupa M, et al. Bombesin antagonists inhibit growth of MDAMB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes[J]. Proc Natl Acad Sci, 2002,99(6):3836-3841.
6. Munday JS, Brennan MM, Kiupel M. Altered expression of beta-catenin, E-cadherin, cycloxygenase-2, and p53 protein by ovine intestinal adenocarcinoma cells [J]. Vet Pathol, 2006,43(5):613-621.
7. Hara S, Kondo Y, Matsuzawa I, et al. Expression of cycloxygenase-2 in human bladder and renal cell carcinoma[J]. Adv Exp Med Biol, 2002, 507:123-126.
8. Burnett BP, Jia Q, Zhao Y, et al. A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation [J]. J Med Food, 2007,10(3):442-451.
9. Yuri M, Sasahira T, Nakai K, et al. Reversal of expression of 15-lipoxygenase-1 to cyclooxygenase-2 is associated with development of colonic cancer[J]. Histopathology, 2007,51(4):520-527.
10. Hammock BD, Ota K. Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities [J]. Toxicol Appl Pharmacol, 1983,71(2):254-265.
11. DuTeaux SB, Newman JW, Morisseau C, et al. Epoxide hydrolases in the rat epididymis: possible roles in xenobiotic and endogenous fatty acid metabolism [J]. Toxicol Sci, 2004,78(2):187-195.
12. Wu S, Moomaw CR, Tomer KB, et al. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart [J]. J Biol Chem, 1996,271(7):3460-3468.
13. Enayetallah AE, French RA, Thibodeau MS, et al. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues[J]. J Histochem Cytochem, 2004,52(4):447-454.
14. Scarborough PE, Ma J, Qu W, et al. P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues[J]. Drug Metab Rev, 1999,31(1):205-234.
15. Graham-Lorence S, Truan G, Peterson JA, et al. An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase[J]. J Biol Chem, 1997,272(2):1127-1135.
16. Spector AA, Fang X, Snyder GD, et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function[J]. Prog Lipid Res, 2004,43(1):55-90.